Revvity | PKI - 销售和管理费用



金融业
股票价格
USD
资产
USD 12.05B
现金及等价物
USD 1.02B
销售成本
USD 312.82M
流动资产
USD 2.3B
流动负债
USD 1.28B
债务
USD 3.35B
股息收益率
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
员工
11K
EPS每股收益
USD 1.41
股本和储备
USD 7.18B
销售毛利
USD 416.87M
债务利息支出
USD 22.99M
利息收入
USD 6.3M
贷款资金
USD 2.63B
市值
USD 14.11B
净收入
USD 51.82M
营业费用
USD 603.55M
营业利润
USD 126.14M
普通股股本
USD 111.63M
PE价格收益
36.47
税前利润
USD 187.24M
销售收入
USD 729.68M
销售和管理费用
USD 278.58M
股票
USD 378.5M
贸易债权人
USD 165.74M
应收帐款人
USD 709.18M


销售和管理费用 更改 日
Agilent USD 465M 11M 2026-03
Align Technology USD 462.67M 2.67M 2026-06
Bio Techne USD 109.34M 4.35M 2026-03
Bio-Rad Laboratories USD 212M 400K 2026-06
Bruker USD 238.9M 3.2M 2026-06
Celltrion KRW 9.32B 3.39B 2026-03
Charles River Laboratories USD 228.9M 69.47M 2026-06
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Danaher USD 2.07B 212M 2026-06
Dentsply International USD 364M 13M 2026-06
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Illumina USD 273M 1000K 2026-06
Intuitive Surgical USD 617.9M 4.6M 2026-06
IQVIA Holdings USD 574M 72M 2026-06
Kangmei Pharma CNY 237.06M 37.35M 2026-03
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Laboratory Of America USD 577.2M 26.2M 2026-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Mesa Laboratories USD 27.31M 380K 2024-09
Mettler Toledo International USD 263.33M 5.01M 2026-06
Myriad Genetics USD 122.3M 6.7M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Organigram Holdings CAD 22.01M 14.28M 2026-03
Ovoca Bio EUR 617K 15K 2025-12
Pacific Biosciences Of California USD 37.24M 25.68M 2025-12
Pharma Mar EUR 17.12M 1.82M 2026-06
Qiagen NV USD 142.39M 11.49M 2026-03
Quest Diagnostics USD 529M 25M 2026-06
Quidel USD 189.7M 9.6M 2026-06
Repligen USD 76.62M 82K 2026-06
Revvity USD 278.58M 24.69M 2026-06
Sartorius EUR 221.3M 0 2026-06
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Thermo Fisher Scientific USD 1.91B 111M 2026-06
Tilray USD 24.85M 1.7M 2025-09
Waters USD 405M 11M 2026-06
Zealand Pharma A/S 104M 12.19M 2026-03
Zz Pientze Pharmaceu CNY 214.31M 42.4M 2026-03